China halts sale of Sun Pharma drug used to treat dementia
Image used for representational purposes. File | Photo Credit: Reuters China’s medicine regulator has ordered a halt to the import, sale and usage of a drug used to treat dementia associated with Alzheimer’s disease made by India’s Sun Pharmaceutical Industries, according to an announcement posted on Monday (January 26, 2026). The National Medical Products Administration…
Read More “China halts sale of Sun Pharma drug used to treat dementia” »